M Uchida

ORCID: 0009-0003-3870-6543
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atrial Fibrillation Management and Outcomes
  • Cancer Diagnosis and Treatment
  • Acute Ischemic Stroke Management
  • Metabolism and Genetic Disorders
  • Venous Thromboembolism Diagnosis and Management
  • DNA and Nucleic Acid Chemistry
  • Cardiac Arrhythmias and Treatments
  • Metal complexes synthesis and properties
  • Cardiac Imaging and Diagnostics
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Vitamin C and Antioxidants Research
  • Blood Pressure and Hypertension Studies
  • Heart Rate Variability and Autonomic Control

The University of Tokyo
2023

Cardiovascular Institute Hospital
2020

Hirosaki University
2016

To clarify the influence of hypertension and blood pressure (BP) control on thromboembolism major hemorrhage in patients with nonvalvular atrial fibrillation, a post hoc analysis J-RHYTHM Registry was performed.A consecutive series outpatients fibrillation enrolled from 158 institutions. Of 7937 patients, 7406 (70.8% men, 69.8±10.0 years) were followed for 2 years or until an event occurred. Hypertension defined as systolic BP ≥140 mm Hg, diastolic ≥90 history hypertension, and/or...

10.1161/jaha.116.004075 article EN cc-by-nc-nd Journal of the American Heart Association 2016-09-01

Background Blood pressure (BP) variability has reportedly been a risk factor for various clinical events. To clarify the influence of BP visit‐to‐visit on adverse events in patients with nonvalvular atrial fibrillation, post hoc analysis J‐RHYTHM Registry was performed. Methods and Results Of 7406 outpatients fibrillation from 158 institutions, 7226 (age, 69.7±9.9 years; men, 70.7%), whom measured 4 times or more (14.6±5.0 times) during 2‐year follow‐up period until occurrence an event,...

10.1161/jaha.120.018585 article EN cc-by-nc-nd Journal of the American Heart Association 2020-12-29

Abstract Aims Contemporary guidelines differ in their recommendations regarding initiating non-vitamin K antagonist oral anticoagulants (NOACs) patients with atrial fibrillation (AF) at low risk of stroke. This study aimed to examine the effectiveness and safety NOACs for low-risk AF a Japanese cohort. Methods results In this retrospective cohort based on JMDC Claims Database extracted between April 2011 November 2022, we identified 13 291 We performed inverse probability treatment weighting...

10.1093/ehjcvp/pvad077 article EN European Heart Journal - Cardiovascular Pharmacotherapy 2023-10-19
Coming Soon ...